2HGS - JenaLib

Asymmetric Unit (6, 6)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	GLU A:144 , ASN A:146 , GLU A:368 , ADP A:500 , MG A:502 , SO4 A:505	BINDING SITE FOR RESIDUE MG A 501
2	AC2	SOFTWARE	GLU A:144 , ADP A:500 , MG A:501 , SO4 A:505 , HOH A:622 , HOH A:735	BINDING SITE FOR RESIDUE MG A 502
3	AC3	SOFTWARE	LYS A:384 , LEU A:410 , ARG A:412 , ARG A:418 , ALA A:453 , HIS A:456 , HOH A:512 , HOH A:552 , HOH A:640 , HOH A:642	BINDING SITE FOR RESIDUE SO4 A 504
4	AC4	SOFTWARE	ARG A:125 , GLU A:144 , ASN A:146 , GLU A:368 , GLY A:369 , ARG A:450 , ADP A:500 , MG A:501 , MG A:502 , GSH A:503 , HOH A:622 , HOH A:623	BINDING SITE FOR RESIDUE SO4 A 505
5	AC5	SOFTWARE	ILE A:143 , GLU A:144 , LYS A:305 , LYS A:364 , GLU A:368 , GLY A:369 , GLY A:370 , ASN A:373 , TYR A:375 , MET A:398 , GLU A:399 , LYS A:400 , ILE A:401 , GLU A:425 , LYS A:452 , ALA A:457 , ASP A:458 , GLY A:459 , MG A:501 , MG A:502 , SO4 A:505 , HOH A:510 , HOH A:528 , HOH A:621 , HOH A:622 , HOH A:623 , HOH A:625	BINDING SITE FOR RESIDUE ADP A 500
6	AC6	SOFTWARE	ARG A:125 , ILE A:148 , SER A:149 , ALA A:150 , SER A:151 , PHE A:152 , GLU A:214 , ASN A:216 , GLN A:220 , ARG A:267 , TYR A:270 , ARG A:450 , GLY A:460 , VAL A:461 , ALA A:462 , SO4 A:505 , HOH A:520 , HOH A:557	BINDING SITE FOR RESIDUE GSH A 503

SS Bonds (0, 0)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (16, 16)

Asymmetric Unit (16, 16)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_003602	A	26	D	GSHB_HUMAN	Disease (GSS deficiency)	759253242	A	A	26	D
02	UniProt	VAR_003603	L	188	P	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	188	P
03	UniProt	VAR_003604	D	219	A	GSHB_HUMAN	Disease (GSS deficiency)	---	A	D	219	A
04	UniProt	VAR_003605	D	219	G	GSHB_HUMAN	Disease (GSS deficiency)	28938472	A	D	219	G
05	UniProt	VAR_025047	R	236	Q	GSHB_HUMAN	Polymorphism	34239729	A	R	236	Q
06	UniProt	VAR_003606	L	254	R	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	254	R
07	UniProt	VAR_003607	R	267	W	GSHB_HUMAN	Disease (GSS deficiency)	121909308	A	R	267	W
08	UniProt	VAR_003608	Y	270	C	GSHB_HUMAN	Disease (GSS deficiency)	---	A	Y	270	C
09	UniProt	VAR_003609	Y	270	H	GSHB_HUMAN	Disease (GSS deficiency)	---	A	Y	270	H
10	UniProt	VAR_003610	R	283	C	GSHB_HUMAN	Disease (GSS deficiency)	121909309	A	R	283	C
11	UniProt	VAR_003611	L	286	Q	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	286	Q
12	UniProt	VAR_078567	L	301	P	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	301	P
13	UniProt	VAR_003612	R	330	C	GSHB_HUMAN	Disease (GSS deficiency)	148640446	A	R	330	C
14	UniProt	VAR_025048	K	437	E	GSHB_HUMAN	Polymorphism	34852238	A	K	437	E
15	UniProt	VAR_003613	G	464	V	GSHB_HUMAN	Disease (GSS deficiency)	---	A	G	464	V
16	UniProt	VAR_003614	D	469	E	GSHB_HUMAN	Disease (GSS deficiency)	---	A	D	469	E

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (16, 32)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_003602	A	26	D	GSHB_HUMAN	Disease (GSS deficiency)	759253242	A	A	26	D
02	UniProt	VAR_003603	L	188	P	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	188	P
03	UniProt	VAR_003604	D	219	A	GSHB_HUMAN	Disease (GSS deficiency)	---	A	D	219	A
04	UniProt	VAR_003605	D	219	G	GSHB_HUMAN	Disease (GSS deficiency)	28938472	A	D	219	G
05	UniProt	VAR_025047	R	236	Q	GSHB_HUMAN	Polymorphism	34239729	A	R	236	Q
06	UniProt	VAR_003606	L	254	R	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	254	R
07	UniProt	VAR_003607	R	267	W	GSHB_HUMAN	Disease (GSS deficiency)	121909308	A	R	267	W
08	UniProt	VAR_003608	Y	270	C	GSHB_HUMAN	Disease (GSS deficiency)	---	A	Y	270	C
09	UniProt	VAR_003609	Y	270	H	GSHB_HUMAN	Disease (GSS deficiency)	---	A	Y	270	H
10	UniProt	VAR_003610	R	283	C	GSHB_HUMAN	Disease (GSS deficiency)	121909309	A	R	283	C
11	UniProt	VAR_003611	L	286	Q	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	286	Q
12	UniProt	VAR_078567	L	301	P	GSHB_HUMAN	Disease (GSS deficiency)	---	A	L	301	P
13	UniProt	VAR_003612	R	330	C	GSHB_HUMAN	Disease (GSS deficiency)	148640446	A	R	330	C
14	UniProt	VAR_025048	K	437	E	GSHB_HUMAN	Polymorphism	34852238	A	K	437	E
15	UniProt	VAR_003613	G	464	V	GSHB_HUMAN	Disease (GSS deficiency)	---	A	G	464	V
16	UniProt	VAR_003614	D	469	E	GSHB_HUMAN	Disease (GSS deficiency)	---	A	D	469	E

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (0, 0)

Exons (12, 12)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:472
 aligned with GSHB_HUMAN | P48637 from UniProtKB/Swiss-Prot  Length:474

    Alignment length:472
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472  
           GSHB_HUMAN     3 TNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV 474
               SCOP domains d2hgsa4 A:3-201,A:304-474 Eukaryotic glutathione synthetase ATP-binding domain                                                                                                                         d2hgsa1 A:202-303 Eukaryotic glutathione synthetase, substrate-binding domain                         d2hgsa4 A:3-201,A:304-474 Eukaryotic glutathione synthetase ATP-binding domain                                                                                              SCOP domains
               CATH domains 2hgsA01 A:3-55,A:158-179,A:406-417                   2hgsA02     2hgsA03 A:68-114,A:304-337                     2hgsA02 A:56-67,A:115-157,A:418-473        2hgsA01               --2hgsA04 A:182-303  [code=3.40.50.1760, no name defined]                                                                   2hgsA03 A:68-114,A:304-337        2hgsA05 A:338-405  [code=3.30.1490.50, no name defined]             2hgsA01     2hgsA02 A:56-67,A:115-157,A:418-473                     - CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...hhhh..hhhhhhhhhhhhhhhhh...eee..........eee........eeehhhhhhhhh.hhhhhhhhhhhhh.hhhhhhhhh.hhhh.hhhhhhhhhhhhhhhh.....eeeeeeeeeeeeee.....eeeeeeeee......hhhhh..hhhhhhhhhhh..hhhhhh.....hhhhhhhhhhhhhhhh.....eeeee.......hhhhhhhhhhhhhh...eeee.hhhhhhheee.....eee....eeeeee.....hhh..hhhhhhhhhhhh...eee..hhhhhhh.hhhhhhhh...hhhhh....hhhhhhhhhh...eee....hhhhhhhhhhhh.hhheeeee..........hhhhhhhhhhh...hhhhheeeee......eeeee.......eeeeeeeeeeeeeeeeee.....eeeeeeeeeeeee.............eee..eee Sec.struct. author
             SAPs(SNPs) (1) -----------------------D-----------------------------------------------------------------------------------------------------------------------------------------------------------------P------------------------------A----------------Q-----------------R------------W--C------------C--Q--------------P----------------------------C----------------------------------------------------------------------------------------------------------E--------------------------V----E----- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------G--------------------------------------------------H------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (2)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:3-43 UniProt: 1-43      Exon 1.3  PDB: A:44-92 UniProt: 44-92            -------------------------Exon 1.5  PDB: A:118-164 UniProt: 118-164      --------------------------------------Exon 1.7  PDB: A:203-230    -------------------------Exon 1.9  PDB: A:256-27Exon 1.10  PDB: A:279-343 UniProt: 279-343                       Exon 1.11  PDB: A:344-371   --------------------------------------------------------------Exon 1.13b  PDB: A:434-474                Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------------------------------------------------------Exon 1.4  PDB: A:92-117   ----------------------------------------------Exon 1.6  PDB: A:164-203                --------------------------Exon 1.8  PDB: A:230-256   ------------------------------------------------------------------------------------------------------------------Exon 1.12  PDB: A:371-434 UniProt: 371-434                      ---------------------------------------- Transcript 1 (2)
                 2hgs A   3 TNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV 474
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (2, 2)

CATH Domains (5, 5)

Pfam Domains (0, 0)

Gene Ontology (23, 23)

Asymmetric Unit(hide GO term definitions)

Chain A (GSHB_HUMAN | P48637)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0043295	glutathione binding	Interacting selectively and non-covalently with glutathione; a tripeptide composed of the three amino acids cysteine, glutamic acid and glycine.
	GO:0004363	glutathione synthase activity	Catalysis of the reaction: L-gamma-glutamyl-L-cysteine + ATP + glycine = ADP + glutathione + 2 H(+) + phosphate.
	GO:0016594	glycine binding	Interacting selectively and non-covalently with glycine, aminoethanoic acid.
	GO:0016874	ligase activity	Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
	GO:0000287	magnesium ion binding	Interacting selectively and non-covalently with magnesium (Mg) ions.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0042277	peptide binding	Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0006520	cellular amino acid metabolic process	The chemical reactions and pathways involving amino acids, carboxylic acids containing one or more amino groups, as carried out by individual cells.
	GO:0006750	glutathione biosynthetic process	The chemical reactions and pathways resulting in the formation of glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins.
	GO:0007399	nervous system development	The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
	GO:0043200	response to amino acid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
	GO:0046686	response to cadmium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
	GO:0031667	response to nutrient levels	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
	GO:0006979	response to oxidative stress	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
	GO:0034612	response to tumor necrosis factor	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
	GO:0009410	response to xenobiotic stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xenobiotic compound stimulus. Xenobiotic compounds are compounds foreign to living organisms.
cellular component
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

Visualization

Interactive Views

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		ADP	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GSH	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Cys A:294 - Pro A:295	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Still Images

Databases and Analysis Tools

Databases

Access by PDB/NDB ID
	2hgs
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	GSHB_HUMAN \| P48637
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	6.3.2.3
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	266130
		Disease Information	:	OMIM

Access by GenAge ID
	0037
		Age Related Information	:	GenAge
	0155
		Age Related Information	:	GenAge

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (4, 6)

Sites (6, 6)